Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 36 Recruiting 25 Completed 13 Not yet recruiting 5 Suspended 4 Terminated 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1

Interventions

pembrolizumab 4 Radiotherapy 4 Radiation 4 ALT-803 4 fludarabine 3 Prednisone 3 Etoposide 3 Cytarabine 3 Cyclophosphamide 3 Cisplatin 3 Biopsy 3 sacituzumab govitecan 2 daratumumab 2 atezolizumab 2 Vincristine 2 Temozolomide 2 Surveys and Questionnaires 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Irinotecan 2 Gemcitabine 2 Doxorubicin 2 Blood Specimen Collection 2 Bevacizumab 2 Androgen Antagonists 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vocimagene amiretrorepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Radiotherapy, Intensity-Modulated × 90 days × Clear all

NCT03953352 2026-04-15

GIRAFE

Institut Claudius Regaud

Phase NA Withdrawn

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡